[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-199481-105":59,"doc-detail-199481-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","uniform-formulary-beneficiary-advisory-panel-notice-of-federal-advisory-committee-meeting","Uniform Formulary Beneficiary Advisory Panel - Notice of Federal Advisory Committee Meeting","","Department of Defense publishes a notice for a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel. The meeting covers review and comments on recommendations related to the Uniform Formulary, including scheduled therapeutic class reviews, a review of newly approved drugs, and utilization management issues. The notice specifies public accessibility, limited seating by pre sign-in, and procedures for submitting written statements to be received at least five business days before the meeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/uniform-formulary-beneficiary-advisory-panel-notice-of-federal-advisory-committee-meeting/199481/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/uniform-formulary-beneficiary-advisory-panel-notice-of-federal-advisory-committee-meeting/199481.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-04",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the Uniform Formulary Beneficiary Advisory Panel meeting?","Question",{"text":112,"@type":113},"The Panel reviews and provides comments on recommendations made to the Director of the Defense Health Agency regarding the Uniform Formulary.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"When and where is the meeting open to the public?",{"text":117,"@type":113},"The meeting is open to the public on Thursday, January 4, 2018, from 9:00 a.m. to 12:00 p.m. at the Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., Washington, DC 20004.",{"name":119,"@type":110,"acceptedAnswer":120},"How can the public submit written statements for the Panel?",{"text":121,"@type":113},"Written statements may be submitted to the Panel’s Designated Federal Officer, and they must be received at least five (5) business days prior to the meeting to be available for Panel consideration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},199481,1788506106,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":14,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":129,"read_time":24,"preview_page_count":4},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","5510–00–NSH–0080—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0081—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0082—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0083—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0084—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0085—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0086—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0087—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0088—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0089—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0090—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0091—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0092—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0093—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0094—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0095—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0096—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0097—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0101—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0102—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0103—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0104—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0105—Stakes/Lath, Survey, Wood  \n5510–00–NSH–0106—Stakes/Lath, Survey, Wood  \nMandatory Source of Supply: Siskiyou Opportunity Center, Inc. , Mt. Shasta, CA  \nContracting Activity: FOREST SERVICE, KLAMATH NATIONAL FOREST  \nNSN—Product Name: 8470–00–NSH–0030—Improved Oxygen Harness  \nMandatory Source of Supply: Employment Source, Inc. , Fayetteville, NC  \nContracting Activity: Army Contracting Command—Aberdeen Proving Ground, Natick Contracting Division.  \nPatricia Briscoe,  \nDeputy Director, Business Operations,(Pricing and Information Management) .[FR Doc. 2017–25854 Filed 11–30–17; 8:45 am]  \nBILLING CODE 6353–01–P  \nDEPARTMENT OF DEFENSE Office of the Secretary  \nUniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting  \nAGENCY: Assistant Secretary of Defense (Health Affairs), Department of Defense. ACTION: Notice of Federal Advisory Committee meeting.  \nSUMMARY: The Department of Defense is publishing this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to asthe Panel) .  \nDATES: Open to the public on Thursday, January 4, 2018, from 9:00 [a.m. to](a.m. to) 12:00 p.m.  \nADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW. , Washington, DC 20004.  \nFOR FURTHER INFORMATION CONTACT:  \nCaptain Edward C. Norton, United States Navy, Designated Federal Official, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Email Address: [dha.ncr.health-it.mbx.baprequests@](dha.ncr.health-it.mbx.baprequests@)[ ](dha.ncr.health-it.mbx.baprequests@)[mail.mil](mail.mil).  \nSUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (5 U. S.C. , Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U. S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150.  \nPurpose of Meeting: The Panel will review and comment on recommendations made to the Director of the Defense Health Agency, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.  \nMeeting Agenda:  \n1. Sign-In  \n2. Welcome and Opening Remarks  \n3. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item)  \na. Weight Loss Agents  \nb. Oncological Agents: Multiple Myeloma  \nc. Prenatal Vitamins  \n4. Newly Approved Drugs Review  \n5. Pertinent Utilization Management Issues  \n6. Panel Discussions and Vote Meeting Accessibility: Pursuant to 5  \nU. S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first  \n220 people signing-in. All persons must sign-in legibly.  \nWritten Statements: Pursuant to 41 CFR 102–3.140, the public or interested organizations may submit written statements to the membership of the Panel about its mission and/or the agenda to be addressed in this public meet","cbCaijYcXsno4hQf","https://ap.wps.com/l/cbCaijYcXsno4hQf","pdf",176743,"English","# Uniform Formulary Beneficiary Advisory Panel\n## Meeting summary\n## Dates and public access\n## Contact information\n## Purpose and agenda\n## Written statements and submission deadlines","[{\"question\":\"What is the purpose of the Uniform Formulary Beneficiary Advisory Panel meeting?\",\"answer\":\"The Panel reviews and provides comments on recommendations made to the Director of the Defense Health Agency regarding the Uniform Formulary.\"},{\"question\":\"When and where is the meeting open to the public?\",\"answer\":\"The meeting is open to the public on Thursday, January 4, 2018, from 9:00 a.m. to 12:00 p.m. at the Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., Washington, DC 20004.\"},{\"question\":\"How can the public submit written statements for the Panel?\",\"answer\":\"Written statements may be submitted to the Panel’s Designated Federal Officer, and they must be received at least five (5) business days prior to the meeting to be available for Panel consideration.\"}]","Uniform Formulary Beneficiary Advisory Panel - Notice of Federal Advisory Committee Meeting | PDF"]